Aperçu rapide pour Four and A Half LIM Domains 3 (FHL3) Peptide (ABIN976854)
Antigène
FHL3
(Four and A Half LIM Domains 3 (FHL3))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-FHL3 antibody (Catalog #: ARP50498_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
FHL3
Reactivité: Humain, Souris, Rat
Hôte: Synthetic
BP, BI
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
FHL3
(Four and A Half LIM Domains 3 (FHL3))
Sujet
FHL3 contains 4 LIM zinc-binding domains. It is expressed only in skeletal muscle. FHL3 association with MyoD may contribute to the regulation of MyoD-dependent transcription of muscle genes and thereby myogenesis.LIM proteins are defined by the possession of a highly conserved double zinc finger motif called the LIM domain.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: MGC19547, MGC23614, MGC8696, SLIM2
Protein Interaction Partner: SRF,ACTB,ADAMTSL4,AIMP2,CDC25B,CDC42EP1,CTBP2,FHL2,FHL3,ITGA7,KLF8,LASP1,LNX1,MAPK1,MED15,MZF1,PAK7,PHC2,RBM42,RFX6,SRF,TRIP6,ADAMTSL4,AIMP2,CDC42EP1,CREB1,CTBP2,FHL2,FHL3,FHL5,ITGA7,KLF3,LASP1,LNX1,MED15,PAK7,PHC2,RBM42,RFX6,TRIP6,ZBTB16